Treatable Intellectual Disability

Sly Syndrome (MPS VII)

BIOCHEMICAL DEFECT

Stacks Image 214

DIAGNOSIS

Gene
GUSB (AR)

Diagnostic Test
Urine Glycosaminoglycans

Stacks Image 215

SIGNS & SYMPTOMS

Neurological
Dementia, white matter abnormalities (MRIscan)

Non-Neurological
Dysmorphisms, corneal clouding, hepato
(-spleno)megaly, dysostoses

Stacks Image 216

THERAPY

Treatment
Haematopoietic Stemcell Transplantation

Level of Evidence
4-5

Clinical Practice
Individual Basis

Treatment Effect
Stabilizes clinical deterioration



Stacks Image 217
Sly Syndrome

Sly Syndrome (MPS VII)

Mucopolysaccharidosis type VII (MPS VII) is a very rare lysosomal storage disease belonging to the group of mucopolysaccharidoses. Less than 40 patients with neonatal to moderate presentation have been reported since the initial description of the disease by Sly in 1973. The clinical phenotype is extremely variable and similar to MPS I; it is characterized by facial dysmorphisms, skeletal deformities, cardiac and ocular involvement as well as delay in motor and intellectual development. The disease is caused by beta-D-glucuronidase deficiency, which leads to accumulation of several glycosaminoglycans (dermatan sulfate (DS), heparan sulfate (HS), and chondroitin sulfate (CS)) in lysosomes. (Source: Orphanet)

No information available from this source.

This disease is not (yet) listed on their website.